Post-effective amendment to a registration statement that is not immediately effective upon filing

Stock-Based Compensation (Details 1)

v3.19.3.a.u2
Stock-Based Compensation (Details 1) - Omnibus Incentive Plan 2014 - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Dec. 31, 2017
Number of Shares      
Outstanding, Balance at the beginning 9,142,273 870,000  
Granted   2,393,501  
Expired   (48,000)  
Forfeited   (427,000)  
Outstanding, Balance at the ending   9,142,273 870,000
Stock Option      
Number of Shares      
Outstanding, Balance at the beginning 2,405,000 1,130,000  
Granted 1,262,642 1,750,000  
Expired (196,875) (48,000)  
Forfeited (153,125) (427,000)  
Outstanding, Balance at the ending 3,317,642 2,405,000 1,130,000
Exercisable 1,807,333 859,417  
Vested and Expected to Vest   2,405,000  
Weighted Average Exercise Price      
Outstanding, Balance at the beginning $ 0.33 $ 0.60  
Exercise Price 0.30 0.30  
Expired 0.26 2.57  
Forfeited 0.26 0.66  
Outstanding, Balance at the ending 0.33 0.33 $ 0.60
Exercisable $ 0.43 0.37  
Vested and expected to vest   $ 0.33  
Weighted Average Remaining Contractual Term (Years) 8 years 7 months 2 days 8 years 8 months 16 days 6 years 10 months 21 days
Weighted Average Remaining Contractual Term (Years), Exercisable 7 years 10 months 24 days 7 years 4 months 21 days  
Weighted Average Remaining Contractual Term (Years), Vested and Expected to Vest   8 years 8 months 16 days  
Aggregate Intrinsic Value [1]   $ 182,000  
Aggregate Intrinsic Value, Exercisable [1]   36,458  
Aggregate Intrinsic Value, Vested and Expected to Vest [1]   $ 182,000  
[1] The aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company's stock exceeded the exercise price of the stock options at December 31, 2018 for those stock options for which the quoted market price was in excess of the exercise price ("in-the-money options").